May 2026 is shaping up to be a messy year for gynecology semantics. And by messy, I mean finally.
Three major pieces of research landed this month, all screaming the same thing from different angles. We don’t know what we’re doing with women’s bodies. Or maybe we just refuse to care.
Let’s break it down.
The Name Game: PMOS
Polycystic Ovary Syndrome (PCOS). You know the one. The label stuck around for decades because, well, tradition. It also stuck because it’s a lie.
The condition is not defined by harmful ovarian cysts
Most women with the diagnosis don’t even have “cysts.” They have enlarged follicles. Big difference. The name “Polycystic” implied a structural defect that often doesn’t exist. It confused patients. It confused doctors. It led to shame, especially in cultures where fertility is a woman’s entire identity package. If your ovaries are “broken,” how are you supposed to reproduce? The emotional toll was high.
So, a global team of clinicians and patients got together. They used surveys. They held workshops. They ran marketing analyses. Sounds corporate? Maybe. But they had to. They landed on Polyendocrine Metabolic Ovaryan Syndrome (PMOS).
Why the change?
- Accuracy: It reflects metabolic, reproductive, and skin issues.
- Safety: It’s culturally softer.
- Visibility: It covers the mental health crash, not just the reproductive one.
Affects 170 million people worldwide. That is not a niche group. That is a global health movement in the making.
But here’s the snag. Backlash is immediate. Some critics argue this renaming exercise was a waste of bandwidth. “Where are the cures?” they ask. “Where is the money?” One article claimed the PCOS community is now divided.
Is a new name going to pay for your meds? Probably not.
But is an old name going to help you get diagnosed? Also no.
Perhaps the anger comes from the feeling that we spent energy on labels instead of labs. A valid point. Yet, how you frame a disease changes how people talk about it. If I say you have a “defective” ovary, you hide. If I say you have a complex metabolic syndrome, you might seek care.
What’s the play now? Does treating depression differ when you frame the root as PMOS rather than just “hormonal mood swings”? We’ll find out.
The Intersection of Pain
Then there’s endometriosis.
Rachel Warner and Jodie C. Avery from Australia wrote a narrative review that reads like a indictment of standard medical practice. Their thesis? Medicine treats the body like a machine. Endometriosis proves that model wrong.
Endo isn’t just “bad periods.” It’s inflammation. It’s pain that ruins your life. And it is wildly underdiagnosed. Especially for marginalized people.
The researchers reviewed 65 articles and found four grim truths:
- Doctors dismiss symptoms. “Normal period pain.” We’ve heard this a thousand times.
- Trauma amplifies pain. If you’ve been traumatized by healthcare before, you’ll hide.
- Erasure happens. Non-white, non-cis, non-heteronormative patients are left out of the data.
- Marginalized communities are the real advocates.
The “ideal patient” in medicine is white, wealthy, athletic, and straight. If you aren’t that, you get dismissed.
The solution isn’t more drugs. It’s trauma-informed care. It’s bringing feminism back into medicine. Reproductive justice frameworks are missing from most hospital corridors. They should be on the wall.
How many providers actually know what endo is beyond “scar tissue”? Ask them. Watch them squirm.
Menstrual Cycle as Vital Sign
Finally, we come to mood.
Lambert, Nolan, and Schmalenberger (UK and Germany) published in the British Journal of Clinical Psychology. They make a case that should have been settled decades ago:
Your period cycle is a vital sign.
For 90% of menstruators, hormonal shifts are mild. Fine. Manageable. But for those with Premenstrual Dysphoric Disorder (PMDD), it is debilitating. Depression. Rumination. Brain fog. Physical pain.
And then there’s PME — Premenstrual Exacerbation. If you have baseline anxiety or depression, your cycle can turn it into a nightmare.
Current psychology training ignores this. Why? No one claims jurisdiction. Gynecologists say “mood issues.” Psychologists say “hormonal issues.” Patients say “please help.”
The fix?
- Track it. Daily symptoms. No exceptions.
- Teach it. Give patients info on timing and patterns.
- Intervene. Use evidence-based methods for cyclical symptoms.
It seems simple. Track the bleed. Note the mood. Connect the dots.
Yet, PMDD gets misdiagnosed as Bipolar. All the time. A new set of guidelines might stop that. Could recognizing the cycle actually reduce the bipolar misdiagnosis rate? That seems like a good use of paper and ink.
So?
We renamed a syndrome to remove stigma. We argued that endometriosis requires a feminist, trauma-informed approach. We said mental health professionals must treat the menstrual cycle as data.
It feels like a lot of talking.
Does it help the woman in the ER tonight, holding her stomach in agony?
Maybe not immediately. But names matter. Frameworks matter. Who gets to define “normal” matters even more.
We are still figuring this out.
Which means we’re just getting started.
